Baidu
map
FITOTERAPIA 润色咨询

FITOTERAPIA

出版年份：1947 年文章数：3827 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：6.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2024-11-21 ms3000000012678796 来自山东省

    偏重的研究方向：药理;中药
    经验分享：慢死了，提交19天了一直submit

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2024-03-29 ms7000001891957838 来自江苏省

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向：药代动
    经验分享：提交一直处于submit 状态

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2024-08-03 ms2000001320609758 来自江苏省

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享：5.14 submit
    5.25 with editor
    5.30 under review
    7.4 RRC
    7.12 revision submit to the journal
    7.21 under review
    7.30 RRC
    8.1 revision submit to the journal
    8.1 accept

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2022-11-24 ms9000000732799769 来自重庆

    偏重的研究方向：药理学;药理
    经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2024-06-17 ms9000000553031114 来自浙江省

    Submission Questionnaire _Fitoterapia这个到底在哪儿找呀

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2023-10-05 ms1000001090708001 来自云南省

    审稿速度:2.0
    偏重的研究方向：天然化合物
    经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？

    18

    展开18条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2024-05-28 ms2000001320609758

    请问with editor 多久啊

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2019-06-28 小十二小事儿

    中药提取物动物药理收吗

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2019-10-31 憨憨在奔跑

    请问各位，真的很快吗？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2238260, encodeId=d4c2223826021, content=偏重的研究方向：药理;中药<br>经验分享：慢死了，提交19天了一直submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ba8469778, createdName=ms3000000012678796, createdTime=Thu Nov 21 20:08:37 CST 2024, time=2024-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2218310, encodeId=de8422183103d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：5.14 submit<br>5.25 with editor<br>5.30 under review<br>7.4 RRC<br>7.12 revision submit to the journal <br>7.21 under review<br>7.30 RRC<br>8.1 revision submit to the journal <br>8.1 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Sat Aug 03 18:12:02 CST 2024, time=2024-08-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210339, encodeId=3fa022103390e, content=Submission Questionnaire _Fitoterapia这个到底在哪儿找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724d9058866, createdName=ms9000000553031114, createdTime=Mon Jun 17 15:21:04 CST 2024, time=2024-06-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省)]
    2024-03-29 ms7000001891957838 来自江苏省

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：好

    5

    展开5条回复
共150条页码: 1/15页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map